Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Time to lysis determines phage sensitivity to a cytidine deaminase toxin/antitoxin bacterial defense system

View through CrossRef
ABSTRACT Toxin-antitoxin (TA) systems are ubiquitous two-gene loci that bacteria use to regulate cellular processes such as phage defense. Here, we demonstrate the mechanism by which a novel type III TA system, avcID , is activated and confers resistance to phage infection. The toxin of the system (AvcD) is a deoxycytidylate deaminase that converts deoxycytidines (dC) to dexoyuridines (dU), while the RNA antitoxin (AvcI) inhibits AvcD activity. We have shown that AvcD deaminated dC nucleotides upon phage infection, but the molecular mechanism that activated AvcD was unknown. Here we show that the activation of AvcD arises from phage-induced shutoff of host transcription, leading to degradation of the labile AvcI. AvcD activation and nucleotide depletion not only decreases phage replication but also increases the formation of defective phage virions. Surprisingly, infection of phages such as T7 that are not inhibited by AvcID also lead to AvcI RNA antitoxin degradation and AvcD activation, suggesting that depletion of AvcI is not sufficient to confer protection against some phage. Rather, our results support that phage with a longer lysis time like T5 are sensitive to AvcID-mediated protection while those with a shorter lysis time like T7 are resistant. AUTHOR’S SUMMARY Numerous diverse antiphage defense systems have been discovered in the past several years, but the mechanisms of how these systems are activated upon phage infection and why these systems protect against some phage but not others are poorly understood. The AvcID toxin-antitoxin phage defense system depletes nucleotides of the dC pool inside the host upon phage infection. We show that phage inhibition of host cell transcription activates this system by depleting the AvcI inhibitory sRNA, which inhibits production of phage and leads to the formation of defective virions. Additionally, we determined that phage lysis time is a key factor that influences sensitivity to AvcID with faster replicating phage exhibiting resistance to its effects. This study has implications for understanding the factors that influence bacterial host/phage dynamics.
Title: Time to lysis determines phage sensitivity to a cytidine deaminase toxin/antitoxin bacterial defense system
Description:
ABSTRACT Toxin-antitoxin (TA) systems are ubiquitous two-gene loci that bacteria use to regulate cellular processes such as phage defense.
Here, we demonstrate the mechanism by which a novel type III TA system, avcID , is activated and confers resistance to phage infection.
The toxin of the system (AvcD) is a deoxycytidylate deaminase that converts deoxycytidines (dC) to dexoyuridines (dU), while the RNA antitoxin (AvcI) inhibits AvcD activity.
We have shown that AvcD deaminated dC nucleotides upon phage infection, but the molecular mechanism that activated AvcD was unknown.
Here we show that the activation of AvcD arises from phage-induced shutoff of host transcription, leading to degradation of the labile AvcI.
AvcD activation and nucleotide depletion not only decreases phage replication but also increases the formation of defective phage virions.
Surprisingly, infection of phages such as T7 that are not inhibited by AvcID also lead to AvcI RNA antitoxin degradation and AvcD activation, suggesting that depletion of AvcI is not sufficient to confer protection against some phage.
Rather, our results support that phage with a longer lysis time like T5 are sensitive to AvcID-mediated protection while those with a shorter lysis time like T7 are resistant.
AUTHOR’S SUMMARY Numerous diverse antiphage defense systems have been discovered in the past several years, but the mechanisms of how these systems are activated upon phage infection and why these systems protect against some phage but not others are poorly understood.
The AvcID toxin-antitoxin phage defense system depletes nucleotides of the dC pool inside the host upon phage infection.
We show that phage inhibition of host cell transcription activates this system by depleting the AvcI inhibitory sRNA, which inhibits production of phage and leads to the formation of defective virions.
Additionally, we determined that phage lysis time is a key factor that influences sensitivity to AvcID with faster replicating phage exhibiting resistance to its effects.
This study has implications for understanding the factors that influence bacterial host/phage dynamics.

Related Results

Stability of the GraA Antitoxin Depends on Growth Phase, ATP Level, and Global Regulator MexT
Stability of the GraA Antitoxin Depends on Growth Phase, ATP Level, and Global Regulator MexT
ABSTRACTBacterial type II toxin-antitoxin systems consist of a potentially poisonous toxin and an antitoxin that inactivates the toxic protein by binding to it. Most of the toxins ...
What makes a temperate phage an effective bacterial weapon?
What makes a temperate phage an effective bacterial weapon?
Abstract Temperate bacteriophages (phages) are common features of bacterial genomes and can act as self-amplifying biological weapons, killing su...
The entry of diphtheria toxin into the mammalian cell cytoplasm: evidence for lysosomal involvement.
The entry of diphtheria toxin into the mammalian cell cytoplasm: evidence for lysosomal involvement.
Lysosomotropic amines, such as ammonium chloride, are known to protect cells from the cytotoxic effects of diphtheria toxin. These drugs are believed to inhibit the transport of th...
Bacterial LomR Induces the Vibriophage VP882 VqmA-Directed Quorum-Sensing Lysogeny-Lysis Transition
Bacterial LomR Induces the Vibriophage VP882 VqmA-Directed Quorum-Sensing Lysogeny-Lysis Transition
SUMMARY The bacterial cell-cell communication process called quorum sensing enables groups of bacteria to synchronously alter behavior in respons...
Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection
Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection
Phage-derived therapies comprise phage therapy and the use of phage-derived proteins as anti-bacterial therapy. Bacteriophages are natural viruses that target specific bacteria. Th...
The Meselson–Stahl Experiment
The Meselson–Stahl Experiment
AbstractThe ‘Meselson–Stahl experiment’, which established the semiconservative mode ofdeoxyribonucleic acid (DNA)replication, is situated in its scientific, historical and institu...

Back to Top